Jura Health Awarded $250,000 Early Stage Capital and Retention Matching Grant

We’re excited to share that Jura Health has been awarded a $250,000 Early Stage Capital and Retention matching grant through Colorado’s Advanced Industries Accelerator Program. This support strengthens our mission to make genetic testing universally accessible, support rare families, and shorten the time to diagnosis and treatment from years to days.

For those interested in supporting our growth, with this award we also gain access to the Advanced Industries Investment Tax Credit which offers 25% to 35% per investment up to $100,000 for early-stage investors.

Next
Next

Jura Health Welcomed by Louisiana Medicaid as an Approved Provider for Suspected Rare Diseases Testing.